J&J | JNJ - Creditori Commerciali

Prezzo Delle Azioni
227.79
Cambio Giornaliero
2.45 1.09%
Mensile
-6.06%
Annuale
46.10%
Q2 Previsione
222.63




Creditori Commerciali Cambiamento Data
AbbVie USD 3.59B 28.65B 2025-12
Abbott USD 4.24B 117M 2025-12
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Baxter International USD 999M 46M 2025-12
Bayer EUR 7.08B 700M 2025-12
Becton, Dickinson and Co. USD 6.14B 4.16B 2025-12
Biogen USD 432M 18.9M 2025-12
Boston Scientific USD 1.14B 142M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
CONMED USD 93.65M 13.44M 2025-12
Cooper Companies USD 225.8M 74.6M 2025-12
Dexcom USD 1.83B 1.38B 2025-12
Edwards Lifesciences USD 227.5M 62.5M 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Gilead Sciences USD 715M 93M 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Globus Medical USD 98.85M 11.62M 2025-12
Insulet USD 75M 26.8M 2025-12
Integra LifeSciences USD 95.73M 3.42M 2025-12
Intuitive Surgical USD 1.85B 68.6M 2026-03
J&J USD 10.46B 1.53B 2026-03
Medtronic USD 2.57B 12M 2025-12
Merck USD 4.15B 102M 2025-09
Merit Medical Systems USD 60.55M 4.19M 2025-12
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
Stryker USD 1.5B 56M 2025-09
Tandem Diabetes Care USD 47.07M 414K 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Zimmer Biomet Holdings USD 303M 12.3M 2025-12
Zoetis USD 487M 77M 2025-12